Yvan Fischer

This inventor holds 8 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Solvay Pharmaceuticals, Gmbh, Abbott Products Gmbh. Active years: 2007-2012.

USPTO Granted Patents = 8 (Patent Applications = 2)

% Patents Active = 12.5

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 2

Average Co-Inventor Count = 10.2

ph-index = 1

Forward Citations = 9(Granted Patents)

Company Filing History:

7 out of 77

Solvay Pharmaceuticals, Gmbh

Years Active: 2007-2012

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8273905 - [object Object] (2012-09-25),

2. 7714150 - [object Object] (2010-05-11),

3. 7534903 - [object Object] (2009-05-19),

4. 7452875 - Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them (2008-11-18),

5. 7427611 - Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them (2008-09-23),

6. 7410962 - Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them (2008-08-12),

7. 7368582 - Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them (2008-05-06),

8. 7262184 - Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them (2007-08-28),

Title: The Innovative Journey of Yvan Fischer

Introduction: Yvan Fischer, an accomplished inventor based in Barsinghausen, Germany, has made significant contributions to the field of pharmaceutical science. With a total of eight patents to his name, Fischer's work primarily revolves around the development of novel compounds aimed at enhancing therapeutic treatments.

Latest Patents: Among his latest patents are innovative compounds corresponding to a specific formula, designated as Formula I. These patents not only outline the composition of these compounds but also detail a process for their preparation alongside intermediate products involved in this process. Furthermore, Fischer's patents encompass pharmaceutical compositions that leverage these compounds and related methods of treatment, underscoring his commitment to advancing medical therapy.

Career Highlights: Yvan Fischer has built a substantial career with key roles in notable organizations such as Solvay Pharmaceuticals and Abbott Products. His experiences in these companies have further enriched his expertise in pharmaceutical research and development, allowing him to push the boundaries of innovation in drug formulation.

Collaborations: Throughout his career, Fischer has had the privilege of collaborating with esteemed colleagues like Dieter Ziegler and Michael Weske. These collaborations have not only facilitated the exchange of ideas but have also fostered an environment conducive to groundbreaking discoveries in the realm of pharmaceuticals.

Conclusion: Yvan Fischer's innovative pursuits and impressive portfolio of patents highlight his pivotal role in the pharmaceutical industry. As he continues to explore new horizons in drug development, Fischer's contributions stand as a testament to the power of innovation in improving health outcomes worldwide.